In these turbulent times for the health sector, good communication with patients is more important than ever. Millennium’s Isabelle Mercier tells EHM about the rising power of patient influence in the realm of pharmaceutical marketing.
Brian Kotzin, Vice President of Medical Sciences at Amgen, tells EHM how biomarkers help translate basic science into medicine, and how increased funding for research has led to an explosion in innovation.
Clinical trials play a vital part in the development of life-saving medicines, and healthcare reform has placed their conduct under even more scrutiny. In times like these, the establishment of an international set of standards for data exchange has become an important goal, as CDISC’s Dave Iberson-Hurst and Tim Jaeger tell EHM.